Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role and Mechanisms of Loop Gain and Associated Parameters in the Reversion of OSA Treated by Either CPAP or Cardiac Valve Replacement

NCT03839654 is registered in ClinicalTrials.gov with Nanjing Medical University as lead sponsor.

NCT NCT03839654
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03839654 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role and Mechanisms of Loop Gain and Associated Parameters in the Reversion of OSA Treated by Either CPAP or Cardiac Valve Replacement
Lead sponsor
Nanjing Medical University
Phase
Not applicable
Overall status
Unknown status
Start date
January 31, 2020
Completion date
December 31, 2023
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart valve diseases, obstructive sleep apnea of adult